(NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced submission of its 510(k) application to the Food and ...
CapsoVision, a medical device company, submitted a 510(k) application to the FDA for an AI-assisted module designed for its CapsoCam Plus capsule endoscopy platform.  The tool aims to improve ...
CapsoVision, Inc. ( ($CV) ) has shared an announcement. On December 29, 2025, CapsoVision, Inc. announced it had submitted a 510(k) application to ...
The only capsule endoscopy system with comprehensive 360° panoramic imaging and no wearable equipment, now available for pediatric patients, ensuring a gentler, stress-free alternative to traditional ...
SARATOGA, Calif., Jan. 21, 2025 /PRNewswire/ -- CapsoVision, Inc., a leader in innovative endoscopic capsule technology, today announced that its award-winning product, the CapsoCam Plus® capsule ...
PENTAX Medical, a healthcare industry leader in diagnostic and therapeutic endoscopy solutions, announced today an exclusive distribution agreement with CapsoVision for their CapsoCam Plus ® Capsule ...